Industries > Pharma > Drug Discovery Outsourcing Market Report 2020-2030

Drug Discovery Outsourcing Market Report 2020-2030

Forecasts by Service Type (Chemistry Services, Biology Services, Lead Identification & Screening Services, Lead Optimisation Services), Molecule Type (Large Molecule Drugs, Small Molecule Drugs), Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) PLUS COVID-19 Recovery Scenarios and Profiles of Leading Drug Discovery Outsourcing Companies

PUBLISHED: 24 August 2020
PAGES: 490
PRODUCT CODE: PHA0407

Clear
WOOCS 2.2.1

Discovery Outsourcing Market–our new study reveals trends, R&D progress, and predicted revenues
Where is the drug discovery outsourcing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 490-page report provides 327 tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

Discover sales predictions for the world market and submarkets

Drug Discovery Outsourcing Market: By Service Type
• Chemistry Services
• Biology Services
• Lead Identification & Screening Services
• Lead Optimisation Services

Drug Discovery Outsourcing Market: By Molecule Type
• Large Molecule Drugs
• Small Molecule Drugs

Drug Discovery Outsourcing Market: By Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

• North America
– U.S.
– Canada

• Europe
– Germany
– France
– United Kingdom
– Italy
– Spain
– Russia
– Rest of Europe

• Asia Pacific
– China
– Japan
– India
– Australia
– South Korea
– Rest of Asia Pacific

• Latin America
– Brazil
– Mexico
– Rest of Latin America

• Middle East and Africa
– GCC
– South Africa
– Rest of Middle East and Africa

Drug Discovery Outsourcing Market Report 2020-2030

The report also includes profiles and for some of the leading companies in the drug discovery outsourcing market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Drug Discovery Outsourcing Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market report helps you
In summary, our 490-page report provides you with the following knowledge:

• Revenue forecasts to 2030 for Drug Discovery Outsourcing Market, with forecasts for Service Type, Molecule Type, and Therapeutic Area, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the drug discovery outsourcing market in North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Drug Discovery Outsourcing Market. Some of the company’s profiled in this report include Evotec, GVK Bio, Charles River Laboratories, LabCorp, Domainex Ltd, Genscript Biotech Corporation, Jubilant Biosys Ltd – Gilead Sciences, Viva Biotech, WuXi AppTec, Dalton Pharma, Eurofins, and Syngene, Selvita.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Drug Discovery Outsourcing Market Analysis : Forecasts report between 2020 to 2030. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category